{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:52:58Z","timestamp":1762505578444,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.arcmed.2009.10.008","type":"journal-article","created":{"date-parts":[[2010,3,23]],"date-time":"2010-03-23T06:34:36Z","timestamp":1269326076000},"page":"693-704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Vaccines against Influenza A (H1N1) Pandemic"],"prefix":"10.1016","volume":"40","author":[{"given":"Jose Luis","family":"Valdespino-Gomez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Garcia-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Ponce de Le\u00f3n-Rosales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2009.10.008_bib1","unstructured":"World Health Organization.Pandemic (H1N1) 2009\u2014update 67. http:\/\/www.who.int\/csr\/don\/2009_09_25\/en\/index.html (accessed October 1, 2009)."},{"key":"10.1016\/j.arcmed.2009.10.008_bib2","unstructured":"National Center for Biotechnology Information. GenBank sequences from 2009 H1N1influenza outbreak. http:\/\/www.ncbi.nlm.nih.gov\/genomes\/FLU\/SwineFlu.html (accessed May 5, 2009)."},{"key":"10.1016\/j.arcmed.2009.10.008_bib3","unstructured":"World Health Organization. Vaccines for the new influenza A(H1N1). http:\/\/www.who.int\/csr\/disease\/swineflu\/frequently_asked_questions\/vaccine_preparedness\/en\/index.html (accessed May 9, 2009)."},{"key":"10.1016\/j.arcmed.2009.10.008_bib4","unstructured":"ClinicalTrials.gov. A service of the US National Institutes of Health. http:\/\/clinicaltrials.gov\/ct2\/home (accessed September 30, 2009)."},{"key":"10.1016\/j.arcmed.2009.10.008_bib5","unstructured":"PubMed Central.http:\/\/www.pubmedcentral.nih.gov (accessed September 28, 2009)."},{"key":"10.1016\/j.arcmed.2009.10.008_bib6","unstructured":"World Health Organization. Availability of two new candidate reassortant vaccine viruses for pandemic (H1N1) 2009 virus vaccine development X-181 and X-181A14. September 2009. http:\/\/www.who.int\/csr\/resources\/publications\/swineflu\/x_181_x_181a.pdf (accessed October 1, 2009)."},{"key":"10.1016\/j.arcmed.2009.10.008_bib7","unstructured":"World Health Organization. Characteristics of the emergent influenza A (H1N1) viruses and recommendations for vaccine development. May 26, 2009."},{"key":"10.1016\/j.arcmed.2009.10.008_bib8","unstructured":"World Health Organization. Pandemic influenza vaccine manufacturing process and timeline. http:\/\/www.who.int\/csr\/disease\/swineflu\/notes\/h1n1_vaccine_20090806\/en\/index.html (accessed August 28, 2009)."},{"key":"10.1016\/j.arcmed.2009.10.008_bib9","unstructured":"World Health Organization. Pandemic influenza vaccines: current status. Pandemic (H1N1) 2009 briefing note 11. http:\/\/www.who.int\/csr\/disease\/swineflu\/notes\/pandemic_influenza_vaccines_20090924\/en\/index.html (accessed October 1, 2009)."},{"key":"10.1016\/j.arcmed.2009.10.008_bib10","unstructured":"World Health Organization. Recommended composition of influenza virus vaccines for use in the 2009\u20132010 northern hemisphere influenza season. http:\/\/www.who.int\/csr\/disease\/influenza\/recommendations2009_10north\/en\/index.html (accessed August 28, 2009)."},{"key":"10.1016\/j.arcmed.2009.10.008_bib11","unstructured":"World Health Organization. Recommended composition of influenza virus vaccines for use in the 2009 southern hemisphere influenza season. http:\/\/www.who.int\/csr\/disease\/influenza\/recommendations2009south\/en\/index.html (accessed August 28, 2009)."},{"key":"10.1016\/j.arcmed.2009.10.008_bib12","unstructured":"World Health Organization. Summary of available candidate vaccine viruses for development of pandemic (H1N1) 2009 virus vaccines July 31st, 2009. http:\/\/www.who.int\/csr\/resources\/publications\/swineflu\/summary_candidate_vaccine.pdf (accessed October 1, 2009)."},{"key":"10.1016\/j.arcmed.2009.10.008_bib13","unstructured":"World Health Organization. WHO recommendations on pandemic (H1N1) 2009 vaccines. http:\/\/www.who.int\/csr\/disease\/swineflu\/notes\/h1n1_vaccine_20090713\/en\/index.html (accessed July 20, 2009)."},{"key":"10.1016\/j.arcmed.2009.10.008_bib14","unstructured":"World Health Organization. WHO recommendations on pandemic (H1N1) 2009 vaccines. http:\/\/www.who.int\/csr\/disease\/swineflu\/notes\/h1n1_vaccine_20090713\/en\/index.html (accessed August 28, 2009)."},{"key":"10.1016\/j.arcmed.2009.10.008_bib15","unstructured":"Secretaria de Salud. Mexico. http:\/\/portal.salud.gob.mx\/contenidos\/inicio\/mapa_sitio.html (accessed September 28, 2009)."},{"key":"10.1016\/j.arcmed.2009.10.008_bib16","first-page":"1","article-title":"Use of Influenza A (H1N1) 2009 Monovalent Vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2009","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.arcmed.2009.10.008_bib17","doi-asserted-by":"crossref","unstructured":"Greenberg M, Lai M, Hartel G, et\u00a0al. Response after One Dose of a Monovalent Influenza A (H1N1) 2009 Vaccine\u2014Preliminary Report. Published at www.nejm.org September 10, 2009 (10.1056\/NEJMoa0907413) 2009.","DOI":"10.1056\/NEJMoa0907413"},{"key":"10.1016\/j.arcmed.2009.10.008_bib18","doi-asserted-by":"crossref","unstructured":"Clark T, Pareek M, Hoschler K, et\u00a0al. Trial of Influenza A (H1N1) 2009 Monovalent MF59-Adjuvanted Vaccine\u2014Preliminary Report. Published at www.nejm.org September 10, 2009 (10.1056\/NEJMoa0907650).","DOI":"10.1056\/NEJMoa0907650"},{"key":"10.1016\/j.arcmed.2009.10.008_bib19","doi-asserted-by":"crossref","first-page":"b3928","DOI":"10.1136\/bmj.b3928","article-title":"Partial protection of seasonal trivalent inactivated vaccine against the new A (H1N1) 2009 pandemic influenza. A case control study in Mexico City","volume":"339","author":"Garc\u00eda-Garc\u00eda","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.arcmed.2009.10.008_bib20","unstructured":"http:\/\/clinicaltrials.gov\/"},{"key":"10.1016\/j.arcmed.2009.10.008_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1503\/cmaj.061435","article-title":"Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women","volume":"176","author":"Dodds","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.arcmed.2009.10.008_bib22","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/0002-9378(59)90570-8","article-title":"Deaths from Asian influenza associated with pregnancy","volume":"78","author":"Freeman","year":"1959","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.arcmed.2009.10.008_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1172\/JCI103791","article-title":"Studies on influenza in the pandemic of 1957\u20131958. II. Pulmonary complications of influenza","volume":"38","author":"Louria","year":"1959","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.arcmed.2009.10.008_bib24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/infdis\/168.3.647","article-title":"Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants","volume":"168","author":"Englund","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arcmed.2009.10.008_bib25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00006454-198704000-00011","article-title":"Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs","volume":"6","author":"Reuman","year":"1987","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.arcmed.2009.10.008_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/infdis\/140.2.141","article-title":"Immunization of pregnant women with influenza A\/New Jersey\/76 virus vaccine: reactogenicity and immunogenicity in mother and infant","volume":"140","author":"Sumaya","year":"1979","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arcmed.2009.10.008_bib27","first-page":"521","article-title":"Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.arcmed.2009.10.008_bib28","unstructured":"Package Insert\u2014Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur, Inc.) (PDF \u2212 228 KB). http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM182404.pdf (accessed October 2, 2009)."},{"key":"10.1016\/j.arcmed.2009.10.008_bib29","unstructured":"Pandemic influenza A(H1N1)v vaccines authorised via the core dossier procedure. Explanatory note on scientific considerations regarding the licensing of pandemic A(H1N1) vaccines. http:\/\/www.emea.europa.eu\/pdfs\/human\/pandemicinfluenza\/60825909en.pdf (accessed October 2, 2009)."},{"key":"10.1016\/j.arcmed.2009.10.008_bib30","unstructured":"Package Insert\u2014Influenza A (H1N1) 2009 Monovalent (Novartis Vaccines and Diagnostics Limited) (PDF\u2013312 KB). http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM182242.pdf (accessed October 2, 2009)."},{"key":"10.1016\/j.arcmed.2009.10.008_bib31","unstructured":"World Health Organization. Squalene-based adjuvants in vaccines. http:\/\/www.who.int\/vaccine_safety\/topics\/adjuvants\/squalene\/questions_and_answers\/en\/index.html (accessed September 30, 2009)."},{"key":"10.1016\/j.arcmed.2009.10.008_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/exmp.1999.2295","article-title":"Antibodies to squalene in Gulf War syndrome","volume":"68","author":"Asa","year":"2000","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.arcmed.2009.10.008_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jim.2003.11.002","article-title":"Detection of antibodies to squalene. III. Naturally occurring antibodies to squalene in humans and mice","volume":"286","author":"Matyas","year":"2004","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.arcmed.2009.10.008_bib34","doi-asserted-by":"crossref","unstructured":"Neuzil K. Pandemic Influenza Vaccine Policy\u2014Considering the Early Evidence. Published at www.nejm.org September 10, 2009 (10.1056\/NEJMe0908224) 2009.","DOI":"10.1056\/NEJMe0908224"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440909001970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440909001970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:36:59Z","timestamp":1759261019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440909001970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0188440909001970"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2009.10.008","relation":{},"ISSN":["0188-4409"],"issn-type":[{"type":"print","value":"0188-4409"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccines against Influenza A (H1N1) Pandemic","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2009.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}